WELL
WELL
Welltower Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $3.13B ▲ | $2.14B ▲ | $96.44M ▼ | 3.08% ▼ | $0.14 ▼ | $-459.39M ▼ |
| Q3-2025 | $2.63B ▲ | $574.02M ▲ | $280.56M ▼ | 10.68% ▼ | $0.41 ▼ | $978.82M ▲ |
| Q2-2025 | $2.52B ▲ | $558.1M ▲ | $301.89M ▲ | 12% ▲ | $0.46 ▲ | $947.72M ▲ |
| Q1-2025 | $2.39B ▲ | $547.62M ▲ | $257.96M ▲ | 10.8% ▲ | $0.4 ▲ | $843.31M ▲ |
| Q4-2024 | $2.22B | $528.87M | $119.97M | 5.41% | $0.19 | $748.33M |
What's going well?
Sales surged 19% this quarter, showing strong demand. Gross profit also climbed, and the company managed to report a profit at the bottom line.
What's concerning?
Operating expenses exploded, wiping out all operating profits and forcing the company to rely on a one-time gain to show a profit. Margins are shrinking, and share dilution is hurting existing shareholders.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $5.03B ▼ | $67.3B ▲ | $24.1B ▲ | $42.13B ▲ |
| Q3-2025 | $6.81B ▲ | $59.5B ▲ | $20.19B ▲ | $38.76B ▲ |
| Q2-2025 | $4.41B ▲ | $55.83B ▲ | $19.29B ▲ | $35.9B ▲ |
| Q1-2025 | $3.5B ▼ | $53.29B ▲ | $18.71B ▲ | $33.96B ▲ |
| Q4-2024 | $3.51B | $51.04B | $18.47B | $31.96B |
What's financially strong about this company?
The company has a large equity cushion, very little due in the short term, and no risky goodwill or intangible assets. Liquidity is excellent, and most assets are tangible and high quality.
What are the financial risks or weaknesses?
Cash fell sharply this quarter, and debt increased by over $3 billion. Retained losses are large, and receivables are rising faster than cash, which could signal slower collections.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $117.77M ▼ | $654.33M ▼ | $-5.46B ▼ | $3.03B ▼ | $-1.73B ▼ | $646.85M ▼ |
| Q3-2025 | $282.19M ▼ | $858.36M ▲ | $-1.63B ▼ | $3.24B ▲ | $2.42B ▲ | $852.21M ▲ |
| Q2-2025 | $304.62M ▲ | $770.03M ▲ | $-1.4B ▲ | $1.42B ▲ | $913.23M ▲ | $761.38M ▲ |
| Q1-2025 | $257.27M ▲ | $598.96M ▲ | $-2.03B ▲ | $1.31B ▼ | $-101.17M ▼ | $587.44M ▲ |
| Q4-2024 | $123.75M | $559.21M | $-2.21B | $1.59B | $-72.95M | $545.05M |
What's strong about this company's cash flow?
The company still generates positive cash from operations and free cash flow after investments. Cash flow quality is high, with real cash coming in above reported profits.
What are the cash flow concerns?
Cash from operations and profits are both falling, and the business is highly dependent on raising new money from debt and stock sales. Shareholder dilution and rising debt are real risks.
Revenue by Products
| Product | Q3-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Management Service | $1.51Bn ▲ | $1.86Bn ▲ | $1.97Bn ▲ | $2.06Bn ▲ |
Revenue by Geography
| Region | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
CANADA | $160.00M ▲ | $190.00M ▲ | $190.00M ▲ | $200.00M ▲ |
UNITED KINGDOM | $380.00M ▲ | $420.00M ▲ | $450.00M ▲ | $930.00M ▲ |
UNITED STATES | $1.89Bn ▲ | $1.94Bn ▲ | $2.04Bn ▲ | $2.06Bn ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Welltower Inc.'s financial evolution and strategic trajectory over the past five years.
Key positives include strong revenue and cash flow growth, a much healthier balance sheet with lower leverage and ample liquidity, and a leading position in a structurally growing healthcare real estate market. The company’s technology platform, deep operator partnerships, and focus on high-quality, wellness-oriented properties provide meaningful differentiation. Demographic trends and its scale give it a long runway for potential expansion.
Main concerns center on margin compression, rapidly rising overhead costs, and volatile accounting profitability despite larger scale. Persistent negative retained earnings and a growing pile of intangibles point to the risks of an acquisition-heavy strategy. Heavy reliance on equity issuance, suspension of dividends, and sensitivity to capital market conditions add financial and perception risk. Operationally, integration of acquisitions, partner performance, regulation, and interest rates remain important uncertainties.
The overall picture is of a company that has aggressively grown and strategically repositioned itself, emerging with stronger cash generation and a de-risked balance sheet but still needing to prove it can consistently translate scale into durable, high-quality earnings. If Welltower can stabilize margins, integrate acquisitions effectively, and continue to leverage its technology and wellness-focused offerings, it is well-placed to benefit from aging demographics. However, the path forward depends on disciplined execution and a supportive financing and regulatory environment.
About Welltower Inc.
https://www.welltower.comWelltower Inc. (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $3.13B ▲ | $2.14B ▲ | $96.44M ▼ | 3.08% ▼ | $0.14 ▼ | $-459.39M ▼ |
| Q3-2025 | $2.63B ▲ | $574.02M ▲ | $280.56M ▼ | 10.68% ▼ | $0.41 ▼ | $978.82M ▲ |
| Q2-2025 | $2.52B ▲ | $558.1M ▲ | $301.89M ▲ | 12% ▲ | $0.46 ▲ | $947.72M ▲ |
| Q1-2025 | $2.39B ▲ | $547.62M ▲ | $257.96M ▲ | 10.8% ▲ | $0.4 ▲ | $843.31M ▲ |
| Q4-2024 | $2.22B | $528.87M | $119.97M | 5.41% | $0.19 | $748.33M |
What's going well?
Sales surged 19% this quarter, showing strong demand. Gross profit also climbed, and the company managed to report a profit at the bottom line.
What's concerning?
Operating expenses exploded, wiping out all operating profits and forcing the company to rely on a one-time gain to show a profit. Margins are shrinking, and share dilution is hurting existing shareholders.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $5.03B ▼ | $67.3B ▲ | $24.1B ▲ | $42.13B ▲ |
| Q3-2025 | $6.81B ▲ | $59.5B ▲ | $20.19B ▲ | $38.76B ▲ |
| Q2-2025 | $4.41B ▲ | $55.83B ▲ | $19.29B ▲ | $35.9B ▲ |
| Q1-2025 | $3.5B ▼ | $53.29B ▲ | $18.71B ▲ | $33.96B ▲ |
| Q4-2024 | $3.51B | $51.04B | $18.47B | $31.96B |
What's financially strong about this company?
The company has a large equity cushion, very little due in the short term, and no risky goodwill or intangible assets. Liquidity is excellent, and most assets are tangible and high quality.
What are the financial risks or weaknesses?
Cash fell sharply this quarter, and debt increased by over $3 billion. Retained losses are large, and receivables are rising faster than cash, which could signal slower collections.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $117.77M ▼ | $654.33M ▼ | $-5.46B ▼ | $3.03B ▼ | $-1.73B ▼ | $646.85M ▼ |
| Q3-2025 | $282.19M ▼ | $858.36M ▲ | $-1.63B ▼ | $3.24B ▲ | $2.42B ▲ | $852.21M ▲ |
| Q2-2025 | $304.62M ▲ | $770.03M ▲ | $-1.4B ▲ | $1.42B ▲ | $913.23M ▲ | $761.38M ▲ |
| Q1-2025 | $257.27M ▲ | $598.96M ▲ | $-2.03B ▲ | $1.31B ▼ | $-101.17M ▼ | $587.44M ▲ |
| Q4-2024 | $123.75M | $559.21M | $-2.21B | $1.59B | $-72.95M | $545.05M |
What's strong about this company's cash flow?
The company still generates positive cash from operations and free cash flow after investments. Cash flow quality is high, with real cash coming in above reported profits.
What are the cash flow concerns?
Cash from operations and profits are both falling, and the business is highly dependent on raising new money from debt and stock sales. Shareholder dilution and rising debt are real risks.
Revenue by Products
| Product | Q3-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Management Service | $1.51Bn ▲ | $1.86Bn ▲ | $1.97Bn ▲ | $2.06Bn ▲ |
Revenue by Geography
| Region | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
CANADA | $160.00M ▲ | $190.00M ▲ | $190.00M ▲ | $200.00M ▲ |
UNITED KINGDOM | $380.00M ▲ | $420.00M ▲ | $450.00M ▲ | $930.00M ▲ |
UNITED STATES | $1.89Bn ▲ | $1.94Bn ▲ | $2.04Bn ▲ | $2.06Bn ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Welltower Inc.'s financial evolution and strategic trajectory over the past five years.
Key positives include strong revenue and cash flow growth, a much healthier balance sheet with lower leverage and ample liquidity, and a leading position in a structurally growing healthcare real estate market. The company’s technology platform, deep operator partnerships, and focus on high-quality, wellness-oriented properties provide meaningful differentiation. Demographic trends and its scale give it a long runway for potential expansion.
Main concerns center on margin compression, rapidly rising overhead costs, and volatile accounting profitability despite larger scale. Persistent negative retained earnings and a growing pile of intangibles point to the risks of an acquisition-heavy strategy. Heavy reliance on equity issuance, suspension of dividends, and sensitivity to capital market conditions add financial and perception risk. Operationally, integration of acquisitions, partner performance, regulation, and interest rates remain important uncertainties.
The overall picture is of a company that has aggressively grown and strategically repositioned itself, emerging with stronger cash generation and a de-risked balance sheet but still needing to prove it can consistently translate scale into durable, high-quality earnings. If Welltower can stabilize margins, integrate acquisitions effectively, and continue to leverage its technology and wellness-focused offerings, it is well-placed to benefit from aging demographics. However, the path forward depends on disciplined execution and a supportive financing and regulatory environment.

CEO
Shankh S. Mitra
Compensation Summary
(Year 2023)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 1985-09-04 | Forward | 3:2 |
ETFs Holding This Stock
Summary
Showing Top 3 of 669
Ratings Snapshot
Rating : B-
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:92.42M
Value:$19.14B
BLACKROCK, INC.
Shares:72.78M
Value:$15.07B
BLACKROCK INC.
Shares:58.98M
Value:$12.22B
Summary
Showing Top 3 of 1,749

